Literature DB >> 28499338

Hyaluronic Acid Molecular Weight-Dependent Modulation of Mucin Nanostructure for Potential Mucosal Therapeutic Applications.

Irene M Hansen1, Morten F Ebbesen1, Liselotte Kaspersen1, Troels Thomsen1, Konrad Bienk1, Yunpeng Cai1, Birgitte Mølholm Malle2, Kenneth A Howard1.   

Abstract

This study investigates the effects of different molecular weight hyaluronic acids (HAs) on the mucosal nanostructure using a pig stomach mucin hydrogel as a mucosal barrier model. Microparticles (1.0 μm) and nanoparticles (200 nm) were used as probes, and their movement in mucin was studied by a three-dimensional confocal microscopy-based particle tracking technique and by Nanoparticle Tracking Analysis (NTA) after addition of high-molecular weight (900 kDa) and low-molecular weight (33 kDa) HA. This demonstrated a molecular weight-dependent HA modulation of the mucin nanostructure with a 2.5-fold decrease in the mobility of 200 nm nanoparticles. To further investigate these mechanisms and to verify that the natural viscoelastic properties of mucus are not undesirably altered, rheological measurements were performed on mucin hydrogels with or without HA. This suggested the observed particle mobility restriction was not attributed to alterations of the natural mucin cohesive and viscoelastic properties but, instead, indicates that the added high-molecular weight HA primarily modulates the mucin nanostructure and mesh size. This study, hereby, demonstrates how mucus nanostructure can be modulated by the addition of high-molecular weight HA that offers an opportunity to control mucosal pathogenesis and drug delivery.

Entities:  

Keywords:  drug delivery; hyaluronic acid; mucin; mucus; nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28499338     DOI: 10.1021/acs.molpharmaceut.7b00236

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Effectiveness of 0.15% hylan A eye drops in ameliorating symptoms of severe dry eye patients in Saudi Arabia.

Authors:  Osama Alsheikh; Sultan Alzaaidi; Jose M Vargas; Eman Al-Sharif; Mohammed Alrajeh; Mohammad A AlSemari; Abdulrahman Alhommadi; Anoud Alsaati; Nouf Aljwaiser; Eman Alshahwan; Mona Abdulhafiz; Rashad Elsayed; Wolfgang G K Müller-Lierheim
Journal:  Saudi J Ophthalmol       Date:  2022-06-13

Review 2.  Modulation of hyaluronan signaling as a therapeutic target in human disease.

Authors:  Stavros Garantziotis
Journal:  Pharmacol Ther       Date:  2021-09-26       Impact factor: 12.310

Review 3.  Why Chain Length of Hyaluronan in Eye Drops Matters.

Authors:  Wolfgang G K Müller-Lierheim
Journal:  Diagnostics (Basel)       Date:  2020-07-23

4.  Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.

Authors:  Raffaele A Incalzi; Stavros Garantziotis; Flavia Galdi; Claudio Pedone; Christopher A McGee; Margaret George; Annette B Rice; Shah S Hussain; Kadambari Vijaykumar; Evan R Boitet; Guillermo J Tearney; John A McGrath; Audrey R Brown; Steven M Rowe
Journal:  Respir Res       Date:  2021-02-01

5.  High Molecular Weight Hyaluronan Promotes Corneal Nerve Growth in Severe Dry Eyes.

Authors:  Gysbert-Botho van Setten; Oliver Stachs; Bénédicte Dupas; Semra Akkaya Turhan; Berthold Seitz; Herbert Reitsamer; Karsten Winter; Jutta Horwath-Winter; Rudolf F Guthoff; Wolfgang G K Müller-Lierheim
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

Review 6.  Hyaluronic Acid: A Review of the Drug Delivery Capabilities of This Naturally Occurring Polysaccharide.

Authors:  Ciara Buckley; Emma J Murphy; Therese R Montgomery; Ian Major
Journal:  Polymers (Basel)       Date:  2022-08-23       Impact factor: 4.967

7.  Hyaluronic Acid in the Intestinal Tract: Influence of Structure, Rheology, and Mucoadhesion on the Intestinal Uptake in Rats.

Authors:  Alexandro Barbosa de Souza; Marco Vinícius Chaud; Thais Francine Alves; Juliana Ferreira de Souza; Maria Helena Andrade Santana
Journal:  Biomolecules       Date:  2020-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.